Left ventricular assist devices and bleeding: adding insult to injury

This publication has 25 references indexed in Scilit:

• Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery
  Blood Coagulation & Fibrinolysis, 2000
• Protamine Reversal of Heparin Affects Platelet Aggregation and Activated Clotting Time After Cardiopulmonary Bypass
  Anesthesia & Analgesia, 1998
• Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices
  The Annals of Thoracic Surgery, 1996
• Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation
  The Annals of Thoracic Surgery, 1996
• Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality
  The Annals of Thoracic Surgery, 1995
• Antiplatelet Components inPanex ginseng
  Planta Medica, 1990
• Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups
  Journal of Pharmacy and Pharmacology, 1987
• EFFECT OF A GINKGOLIDE MIXTURE (BN 52063) IN ANTAGONISING SKIN AND PLATELET RESPONSES TO PLATELET ACTIVATING FACTOR IN MAN
  The Lancet, 1987
• THE ACTIVE PRINCIPLE IN FEVERFEW
  The Lancet, 1981